TGA
The has now been updated to include the following new entries:
- asciminib hydrochloride – pregnancy category D
- anifrolumab – pregnancy category C
- bilastine – pregnancy category B3
- bimekizumab – pregnancy category C
- clobetasol – pregnancy category B3
- difelikefalin – pregnancy category B1
- diroximel fumarate – pregnancy category B3
- dostarlimab – pregnancy category D
- estetrol (as monohydrate) – pregnancy category B3
- faricimab – pregnancy category D
- influenza vaccine (seasonal; recombinant ) – pregnancy category B1
- maribavir – pregnancy category D
- mobocertinib succinate – pregnancy category D
- osilodrostat – pregnancy category D
- patisiran – pregnancy category D
- pegcetacoplan – pregnancy category B3
- pemigatinib – pregnancy category D
- ponesimod – pregnancy category D
- pneumococcal vaccine, polysaccharides conjugate – pregnancy category B1
- rabies vaccine (inactivated) – pregnancy category B2
- selumetinib – pregnancy category D
- selinexor – pregnancy category D
- somapacitan – pregnancy category B1
- somatrogon – pregnancy category B1
- sotorasib – pregnancy category B3
- tepotinib – pregnancy category D
- tixagevimab; cilgavimab – pregnancy category B2
- trastuzumab deruxtecan – pregnancy category D
- treosulfan – pregnancy category D
- vosoritide – pregnancy category B2
The following entries have been amended:
- COVID-19 Vaccine – ChAdOx1-S – pregnancy category from B2 to B1
- COVID-19 Vaccine – elasomeran – change of name: COVID-19 Vaccine (mRNA)
- COVID-19 Vaccine – tozinameran – change of name: COVID-19 Vaccine (mRNA)
- pneumococcal vaccine, 23-valent polysaccharide or 10- or 13-valent conjugate – change of name: pneumococcal vaccine, capsular polysaccharides
- COVID-19 Vaccine – SARS-CoV-2 rS (NVX-CoV2373) – change of name: COVID-19 Vaccine (recombinant protein)
/Public Release. View in full .
